Ono Pharmaceutical Co., Ltd.
JPX: 4528.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Gyo Sagara
- Employees
- 3,853
- Headquarters
- Osaka, Japan
- IPO year
- 2001
- Market cap
- ¥1.2T
- Website
- https://www.ono-pharma.com
Loading 4528…
Loading profile data…Frequently asked questions about 4528
What does Ono Pharmaceutical Co., Ltd. (4528.T) do?
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiti...
Where does 4528.T trade?
Ono Pharmaceutical Co., Ltd. (4528.T) trades on the Tokyo Stock Exchange.
What sector is 4528.T in?
Ono Pharmaceutical Co., Ltd. (4528.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Ono Pharmaceutical Co., Ltd.?
Gyo Sagara is the chief executive officer of Ono Pharmaceutical Co., Ltd. (4528.T).
Where is Ono Pharmaceutical Co., Ltd. headquartered?
Ono Pharmaceutical Co., Ltd. is headquartered in Japan.
Does 4528.T pay a dividend?
Yes — Ono Pharmaceutical Co., Ltd. (4528.T) paid a trailing twelve-month dividend of JPY 80.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4528.T go public?
Ono Pharmaceutical Co., Ltd. (4528.T) completed its initial public offering in 2001.